INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 November 2010
Total net assets |
£99.4m |
NAV per share |
166.3p |
Share price |
137.0p |
Total value of unquoted investments |
£23.3m |
Total number of portfolio companies |
60 |
Cash |
1% NAV |
Cash committed and reserved to unquoted investments |
9% NAV |
Portfolio companies with < 1 year of cash |
10% NAV |
Top Ten Holdings
Company Name |
% NAV |
Celgene |
5.80 |
Micromet |
5.77 |
Amgen |
5.30 |
Shire Ltd |
5.16 |
Gilead Sciences |
4.83 |
Alexion Pharmaceuticals |
3.54 |
Teva |
3.43 |
Insulet |
3.39 |
Genzyme |
3.27 |
Cadent |
3.25 |
|
----------- |
Total |
43.74 |
Geographical Allocation |
% |
United States |
74 |
Europe |
23 |
Australia |
2 |
Cash |
1 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
76 |
Unquoted |
23 |
Cash |
1 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
17 DECEMBER 2010